Concordant analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression between primary colorectal cancer and matched metastases - Wikidata - awgldk - TriplyDB

Concordant analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression between primary colorectal cancer and matched metastases

Concordant analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression between primary colorectal cancer and matched metastases

http://www.wikidata.org/entity/Q28088489

about

Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancer Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach A multidimensional integration analysis reveals potential bridging targets in the process of colorectal cancer liver metastasis Heterogeneity in the colorectal primary tumor and the synchronous resected liver metastases prior to and after treatment with an anti-EGFR monoclonal antibody PTEN mRNA expression is less pronounced in left- than right-sided colon cancer: a retrospective observational study KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancer Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.Utility of KRAS mutation detection using circulating cell-free DNA from patients with colorectal cancer.Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases (18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status.Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal Cancer.The rationale for liquid biopsy in colorectal cancer: a focus on circulating tumor cells.Present and future of metastatic colorectal cancer treatment: A review of new candidate targets.Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors.Progression inference for somatic mutations in cancer.Management of patients with colorectal liver metastasis in eleven questions and answers.Multiplexed Dosing Assays by Digitally Definable Hydrogel Volumes.Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors.Role of circulating free DNA in colorectal cancer.KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma.Current companion diagnostics in advanced colorectal cancer; getting a bigger and better piece of the pie Comparison of KRAS mutation status between primary tumor and metastasis in Chinese colorectal cancer patients.Neoadjuvant chemotherapy affects molecular classification of colorectal tumors.Molecular profiling of colorectal pulmonary metastases and primary tumours: implications for targeted treatment Meta-analysis of the mutational status of circulation tumor cells and paired primary tumor tissues from colorectal cancer patients.Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases.Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.Histopathological and genotypic characterization of metastatic colorectal carcinoma with PD-L1 (CD274)-expression: Possible roles of tumour micro environmental factors for CD274 expression.Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations.Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in BRAF-mutant stage II and III colon cancer.Left Versus Right: Does Location Matter for Refractory Metastatic Colorectal Cancer Patients in Phase 1 Clinical Trials?Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer Spatio-temporal tumor heterogeneity in metastatic CRC tumors: a mutational-based approach

P2860

Q26771952-59818ED1-94A7-423B-B499-047ABD814885 Q28066914-F3C3BD19-8962-458A-BE90-2EF62F26451D Q28647615-4D3101D7-9136-4DB8-A85E-5637A088386D Q33811711-77C2E7CD-92F4-4F2B-80BE-6ED3396DC9F2 Q33858231-0376E14F-1D56-4C80-BE87-A32FE3959A62 Q36050773-AA7F1E4A-E343-4AB4-BC98-0990D13853B6 Q36362489-49F4FA80-0275-4EFB-8004-538C54AC1A28 Q36729538-A11DB968-DB91-44D3-867C-459553EAB9E9 Q37098291-4A023184-B648-4BF7-99CF-BB6A08120A37 Q37352557-B1B9DCD5-F97A-4B8F-AA58-049D2FF37BE3 Q37600941-14664184-1B15-4737-B06D-D02F9FAE5FF0 Q37606706-D43E1CD5-811E-490D-BC38-9C036E22982E Q38470230-12F0E2FB-4FAB-4902-A6F7-0C4F8D188306 Q38648300-41C54550-9E4A-40C5-B190-68E10556AB46 Q38730182-6CD90103-0D15-4033-AA9D-E5E87A316DA7 Q38793244-76694A22-CD0A-4A78-8155-14C396CD2CA5 Q38811107-5D04FFD6-5CE0-43BC-A1E2-C1A86A96F080 Q38815777-0DEAEEA2-6CF2-4524-941C-C6374A465AC4 Q38826084-B3FE6342-FF82-4B26-9FFF-6DEF9128EBEE Q39051652-8BCD88D8-B109-4441-988D-BAB4B71BCBC8 Q39078976-3326D13C-BB74-452B-AC4A-5E6D42B6A3AC Q39172118-0FD1F590-2C29-4AFF-9ABD-9B0E757609F5 Q39704299-56E7D1BA-A4E9-4801-A1D3-CF7D15968E4A Q41228722-779B7D18-9084-4DED-920C-D8D37E7359CA Q42371494-E3573BE9-DE6D-4BA0-8394-D8C83C0098D2 Q43182172-872BFFC1-6F7D-45ED-AEFD-E9C180EB4B7B Q46006378-6F008AF3-8403-49F2-972E-BDF2A445FC82 Q46129222-476589CD-4553-405F-B365-B847C8B974D8 Q47127609-7A39858F-7716-4735-813C-7DE89024C3A2 Q47972738-DFDBDD1E-4E5A-45E8-843B-1A2EC79D7990 Q52641574-3D8A69F8-1DB3-400F-AD63-BDD46D7092E0 Q53340670-67AFADF4-6002-4E95-AB01-C8FC42AB1312 Q56969146-486A3D1B-1DB7-4CD7-9777-1BEC4EFE1FB1 Q57821069-6FE09D8A-3710-43ED-95B7-92431384EF54

P2860

Concordant analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression between primary colorectal cancer and matched metastases

http://www.wikidata.org/entity/Q28088489

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Concordant analysis of KRAS, B ...... cancer and matched metastases

@ast

Concordant analysis of KRAS, B ...... cancer and matched metastases

@en

Concordant analysis of KRAS, B ...... cancer and matched metastases

@nl

type

label

Concordant analysis of KRAS, B ...... cancer and matched metastases

@ast

Concordant analysis of KRAS, B ...... cancer and matched metastases

@en

Concordant analysis of KRAS, B ...... cancer and matched metastases

@nl

prefLabel

Concordant analysis of KRAS, B ...... cancer and matched metastases

@ast

Concordant analysis of KRAS, B ...... cancer and matched metastases

@en

Concordant analysis of KRAS, B ...... cancer and matched metastases

@nl

P1433

Q28088489-51924D43-7194-445E-A8AC-7223450BCD18

P1476

Q28088489-EA894166-483A-4BCE-80B0-3EC61FAB25A3

P2093

Q28088489-1792A649-E61C-461F-8AEB-877903C53CB4

Q28088489-1A3B2B19-CFB2-4E2A-B935-C8C890B3E538

Q28088489-278A87AD-3FE5-4956-AC04-BCC70C559D7F

Q28088489-4A2E1BCF-8E0F-443E-9E64-3B3D4AD092BA

Q28088489-70B51890-78DF-4125-91D7-8D00FF16B966

Q28088489-8829A882-6C59-4DE2-B02E-6067806F45C8

Q28088489-D38B7E22-913C-4AEC-8797-A3E6DCF10F8C

P275

Q28088489-FF0D482C-3D47-4994-A5A8-C470C4251009

P2860

Q28088489-0344DDB4-0657-4D76-ADFC-2C5A03FCB9BD

Q28088489-0CA9233D-78D1-4574-9E07-BDC27DD0F1B5

Q28088489-10F8FEEB-1156-469D-9B14-130A0BB081BD

Q28088489-13251A28-B19E-4E1E-92D8-DF3B67B376BE

Q28088489-173F9B65-409B-4167-A297-992CF3DB48F8

Q28088489-2C2B080D-1F4A-4331-876E-75F61A1FCCDA

Q28088489-2CA071A3-410A-45C9-9955-F0165BEFC16F

Q28088489-32DB3305-F22B-4685-9278-D93DFADDCABB

Q28088489-3801385D-A207-4C33-A887-9FF448EC1ADA

Q28088489-3BABF5DD-78CB-4AAD-B055-B4A54FA06651

P2888

Q28088489-64BDB272-CB5B-4CB4-892E-8BD4CFD47F00

P304

Q28088489-CBF8A3DE-84B3-48A1-82FD-B3E055D55382

P31

Q28088489-2BB80515-39C4-47FE-AD84-422C491DF74B

Q28088489-2b49f12d-afdf-4509-9181-2622f04e4902

Q28088489-98E3301A-0AE1-45C7-8F65-060325CFDFD8

P3181

Q28088489-A02B50CF-86D3-497F-A2B1-8712EBFE32CD

P356

Q28088489-C686EDBC-02D2-4ED2-A98A-D4B29964E8A2

P407

Q28088489-E0D84728-B586-48D4-B068-F2D62806B744

P478

Q28088489-9FCD7AC6-9B3F-4044-A65E-44E8C05E7AD6

P5008

Q28088489-866BAB1F-03F9-488F-A3A9-F873FC0A64DB

P577

Q28088489-ED3FF91D-3E8C-422F-BF40-C60454FC2BEF

P5875

Q28088489-B070F4C7-0C06-43B1-8C0D-42A6B6225ED8

P6179

Q28088489-2C0EDDB1-45DA-41AF-B3A5-03409915BB5D

P698

Q28088489-085F48DE-8587-4C1A-9559-AA7DA67AE1E1

P921

Q28088489-018AF1F1-34B4-4705-B501-4594A262CCC6

Q28088489-6ECAAAD1-97CF-4279-87BD-8F978B27ABFC

Q28088489-75A74268-EABD-4AC2-A2F5-082EFB53E7EC

Q28088489-B8E1A8FD-53F3-413B-9E0B-69334E2C08D6

Q28088489-BD96DBB8-F2EC-4772-90AE-577843D3BAEB

Q28088489-E5CC5EDF-2A79-4B8C-81A9-817CAD5F348A

Q28088489-FE821444-F663-4BCB-93FB-B0DD939FBB5B

P932

Q28088489-BAB9EBAF-E437-43B6-BD55-E7B50193BC98

P3181

P356

P1433

Scientific Reports

P1476

Concordant analysis of KRAS, B ...... cancer and matched metastases

@en

P2093

Chen Mao

http://www.w3.org/2001/XMLSchema#string

Diane Erin Threapleton

http://www.w3.org/2001/XMLSchema#string

Jin-Ling Tang

http://www.w3.org/2001/XMLSchema#string

Jin-Qiu Yuan

http://www.w3.org/2001/XMLSchema#string

Xin-Yin Wu

http://www.w3.org/2001/XMLSchema#string

Yuan-Yuan Yu

http://www.w3.org/2001/XMLSchema#string

Zu-Yao Yang

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

P2860

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis

Molecular changes in the Ki-ras and APC genes in primary colorectal carcinoma and synchronous metastases compared with the findings in accompanying adenomas.

Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer.

KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma.

Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer.

KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue.

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients.

P2888

P304

8065

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

832617

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SREP08065

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273954082

http://www.w3.org/2001/XMLSchema#string

P6179

1050678954

http://www.w3.org/2001/XMLSchema#string

P698

25639985

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

transport protein

colorectal neoplasm

proto-oncogene proteins

neoplasm proteins

P932

4648436

http://www.w3.org/2001/XMLSchema#string